The Effect of Human Amniotic Epithelial Cells on Urethral Stricture Fibroblasts
Overview
Affiliations
Background: Urethral stricture disease (USD) is effectively managed by buccal mucosa (BM) urethroplasty. Lack of adequate healthy BM has led to the use of autologous tissue-engineered BM grafts. Such grafts are costly, not easily scalable and recurrence of the stricture is still a problem. Hence, there is a requirement for cost-effective, scalable cells with innate antifibrotic properties which seem to be fulfilled by human amniotic epithelial cells (HAMECs). The effect of HAMECs on USD is unknown.
Aim: To study the effect of HAMECs-CM on human urethral stricture fibroblast (USF) cells by using migration assay and molecular techniques.
Materials And Methods: USF cells were derived from six patients undergoing urethroplasty. HAMECs were derived from one placenta after delivery. The effect of HAMECs-CM on USF cell migration was observed using a standard scratch assay over a period of 3 days. The effect of HAMECs-CM on the expression levels of markers alpha-smooth muscle actin (α-SMA) and tissue inhibitor of metalloproteinases (TIMP-1) in USF cells was also examined.
Results: The HAMECs-CM suppressed the migration of USF cells in scratch assay. The HAMECs-CM consistently downregulated α-SMA, but not TIMP-1.
Conclusions: HAMECs have shown antifibrotic activity on USF cells in this study.
Relevance For Patients: HAMECs could serve as an alternative cell source for tissue-engineered urethroplasty.
The Regenerative Microenvironment of the Tissue Engineering for Urethral Strictures.
Leng W, Li X, Dong L, Guo Z, Ji X, Cai T Stem Cell Rev Rep. 2024; 20(3):672-687.
PMID: 38305981 DOI: 10.1007/s12015-024-10686-7.
Zhang T, Zhao W, Ren T, Chen J, Chen Z, Wang Y Balkan Med J. 2022; 39(2):107-114.
PMID: 35330555 PMC: 8941225. DOI: 10.4274/balkanmedj.galenos.2021.2021-4-77.
Alishahedani M, Yadav M, McCann K, Gough P, Castillo C, Matriz J PLoS One. 2021; 16(6):e0253669.
PMID: 34143844 PMC: 8213172. DOI: 10.1371/journal.pone.0253669.